Clinical Trial Update: A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating HLX10 in combination with HLX04 for advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• HLX04 (HLX04)
• HLX10

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN